ライフサイエンスコーパス: no use

1 ed penicillins for >or=15 days compared with no use).

2 py use during the 90 days before delivery vs no use.

3 h small-cell lung cancer for >4 years versus no use.

4 cases among 18,145 participants who reported no use.

5 st year only, and 1 186,501 person-years for no use.

6 a given duration of ERT use is compared with no use.

7 utathione-related oxidative burden exposure (no use, 15.8%; irregular use, 3.8%), whereas mold (22.1%

8 The addition of exogenous NO using a NO donor prevented the reduction in iNOS leve

9 re classified as "obese" (O) or "non-obese" (NO) using a BMI cut-off of 25 kg/m(2).

10 iated with higher odds of sICH compared with no use (adjusted odds ratio [AOR], 1.18 [95% CI, 1.10-1.

11 vs. no use), and adjuvant tamoxifen (use vs. no use) and were compared via log-rank tests.

12 de (1 vs. 3), adjuvant chemotherapy (use vs. no use), and adjuvant tamoxifen (use vs. no use) and wer

13 ent, such information is often lacking or of no use, and epidemiological parameters must be estimated

14 r and harder materials, these have little to no use as bulk structural materials without appropriate

15 There was no use-dependent block of IFM/QQQ mutant channels with t

16 pid activation and deactivation kinetics and no use-dependent inactivation.

17 t 3 months of pregnancy, was contrasted with no use during the same time period.

18 ine and GABA(C) receptors displays little or no use-facilitated block.

19 irin NSAIDs compared with those who reported no use (hazard ratio (HR) = 0.92, 95% confidence interva

20 ssociated with tobacco use, as compared with no use (hazard ratio, 1.54; 95% CI, 1.23 to 1.94; P<0.00

21 ith recent use of a statin, as compared with no use (hazard ratio, 2.89; 95% CI, 1.51 to 5.55; P=0.00

22 etection of the DAF-FM reaction product with NO using HPLC and LC-MS/MS.

23 ter the last menstrual period, compared with no use in either month, were 2.8 (95% confidence interva

24 110%) in their urine than women who reported no use in the past 24 h.

25 ivated by pulmonary surfactant, making it of no use in the therapy of pneumonia.

26 nal folic acid supplement use (compared with no use) in the prepregnancy period through the first tri

27 iological relevance, as many pathogens sense NO using iron-sulfur proteins and will be exposed to NO

28 We formed 5 groups (no use, low, medium, high, and very high) based on the f

29 n, or both were randomized to use (n=253) or no use (n=252) of the Bleeper Sv radiation monitor.

30 f methamphetamine use relative to periods of no use (odds ratio [OR], 5.3 [95% CI, 3.4-8.3]; P < .001

31 riods of cannabis use relative to periods of no use (odds ratio, 1.13; 95% CI, 1.03-1.24).

32 1,102,050 episodes of azithromycin use with no use of antibiotic agents (matched in a 1:1 ratio acco

33 a 5-day treatment episode), as compared with no use of antibiotics (rate ratio, 2.85; 95% confidence

34 was total control (no emesis, no nausea, and no use of antiemetic rescue medication) over the initial

35 ic/diastolic blood pressure <140/90 mmHg and no use of antihypertensive drugs).

36 history of overt cardiovascular disease, and no use of antihypertensive medication.

37 o 44-year-old males and females who reported no use of antihypertensive medication.

38 dication; blood pressure 120/</=80 mm Hg and no use of antihypertensive medication; no current smokin

39 (HR, 0.58; 95% CI, 0.44-0.77) compared with no use of antipsychotic medication.

40 more cost-beneficial than nonvaccination and no use of antiviral medication.

41 ength of association between statin use (vs. no use of any cholesterol-lowering drug) and the risk of

42 is of the antiepileptic drug Phenytoin, with no use of any harmful organic solvent.

43 st risk of psychotic disorders compared with no use of cannabis (adjusted OR 5.4, 95% CI 2.81-11.31,

44 r risk of death than those with a history of no use of cannabis.

45 f Veterans had Rapid Recovery with little or no use of care; 15% had a Steady Recovery with initially

46 uses of GPR15, CXCR6, and APJ, but little or no use of CCR2b, CCR3, CCR8, GPR1, and CXCR4.

47 serum total cholesterol level <200 mg/dL and no use of cholesterol-lowering medication; blood pressur

48 mmercially available compression device; and no use of compressive dressing.

49 h no concurrent psychotic or manic symptoms, no use of concurrent psychotropic medications, and no cu

50 , >/= 7 clients per day (AOR, 3.3; 1.8-6.1), no use of condoms (AOR, 3.8, 2.1-7.1), and frequent alco

51 Activity Index (CDAI) <150 [range, 0-600]), no use of corticosteroids or immunosuppressive or biolog

52 complicated small intestinal ulcers despite no use of cyclooxygenase inhibitors.

53 Two respondents reported no use of drug samples, while 4 respondents reported tak

54 with severe laryngopharyngeal disorders and no use of epinephrine.

55 -free survival curves for continuous use and no use of estrogen plus progestin crossed at about 6 yea

56 r menses in the previous year, and to report no use of hormonal contraception.

57 Compared with no use of hormone therapy, the hazard ratio for continuo

58 ge, no history of angina pectoris or asthma, no use of hypoglycemic agent, more activity level, and l

59 L/min per 1.73 m(2), hemoglobin >8 g/dL, and no use of intravenous inotropes or vasopressors.

60 There is no use of isotopic labeling or chemically similar standa

61 phospholipids in the biological extract with no use of isotopic labeling.

62 The method makes no use of mass spectral fingerprints.

63 R, 2.86; 95% CI, 1.25 to 6.56) compared with no use of NSAIDs.

64 n, urban residence, low body mass index, and no use of oral contraceptives.

65 e previous year; 33.6% slaughterers reported no use of protective equipment at work.

66 se (defined as no vomiting, no retching, and no use of rescue medication) during the 25-120 h (delaye

67 nd point; a complete response (no emesis and no use of rescue medication) was a secondary end point.

68 As compared with no use of SSRIs both before and during pregnancy, use du

69 would result in a longer time to death than no use of supplemental oxygen among patients who had sta

70 ph nodes (hazard ratio of 2.7, P =.008), and no use of tamoxifen (hazard ratio of 3.9, P =.027) indep

71 mber of involved lymph nodes (P <.0001), and no use of tamoxifen (P =.0013).

72 l bone lesions compared with those reporting no use of these medications.

73 ent (OR 2.33, 95% CI 1.55-3.55, p < 0.0001), no use of topical ice slush (OR 1.29, 95% CI 1.10-1.49,

74 2 (HER2) (in 15,418 patients in trials with no use of trastuzumab) was not predictive.

75 ion of milk or breakfast cereal <3 times/wk, no use of vitamin D supplements, season, urban residence

76 Hz(1/2) to(14)NO and 0.53 ppbv/Hz(1/2) to(15)NO using only 45 cm active optical path.

77 infections among consistent users reporting no use problems.

78 al cells (BAECs) by measuring superoxide and NO* using spin probe 1-hydroxy-3-methoxycarbonyl-2,2,5,5

79 Compared with those reporting no use, subjects drinking > or =4 cups/day of decaffeina

80 onclude that a fluorescence determination of NO using the DAF family of probes, in combination with t

81 eadmissions, then flagged cases (PPR-Yes/PPR-No) using the 3M-PPR software.

82 Relative to no use, the lower risk of ovarian cancer associated with

83 Amperometric detection of NO using these two electrode systems shows that the sens

84 e, claimed that abstract intelligence was of no use to ancestral humans and could only be explained b

85 SRCs in pretreatment biopsies seems to be of no use to define treatment strategy or prognosis.

86 at a common feature of animal behavior is of no use to small free-swimming organisms.

87 Being of little or no use to the bacterium except during specific stages of

88 reational drug use during the past 3 months (no use, use once per week or less, or use more than once

89 e more than six times per year compared with no use was 1.73 during high school/college v 1.28 at age

90 urrent use of a glucocorticoid compared with no use was 4.9 (95% confidence interval [95% CI] 2.9-8.3

91 eriod ending 2 years before diagnosis versus no use was associated with a decreased risk of bladder c

92 ble analyses, multivitamin use compared with no use was not associated with major CVD events (HR: 1.0

93 HT use from the perimenopausal stage versus no use was validated with prospective daily diary record

94 7 days of aspirin use per week compared with no use were 1.07 (95% CI, 0.70 to 1.63), 0.29 (95% CI, 0

95 The level of drainage amylase is of no use, whereas univariate analysis identified underlyin

96 no use) within 5 km of the home during the second trimes